ArticleNature communications2023

In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome.

Jeroen H A Creemers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.